United States News Todas as matérias

AT&T (NYSE:T) reported third-quarter 2026 revenue of $32.3 billion, up 5.3% year over year, supported by growth in its advanced connectivity businesses.

Integra LifeSciences (NASDAQ:IART) reported third-quarter 2026 revenue of $411.2 million, up 2.3% year over year despite supply disruptions at its Cincinnati manufacturing facility.

Elevance Health (NYSE:ELV) reported third-quarter 2026 operating revenue of $50.4 billion, up 0.7% year over year, supported by its diversified healthcare businesses.

Thermo Fisher Scientific (NYSE:TMO) reported third-quarter 2026 revenue of $12.14 billion, up 9% year over year, supported by growth across its scientific products and services businesses.

Danaher (NYSE:DHR) reported third-quarter 2026 revenue of $6.554 billion, up 8.5% year over year, supported by growth across its life sciences and diagnostics operations.

SCHMID Group (NASDAQ:SHMD) raised its full-year 2026 order intake guidance to more than €150 million following stronger equipment demand during the third quarter.

NVIDIA (NASDAQ:NVDA) introduced DSX POD, a modular reference design intended to accelerate AI factory deployment by integrating and testing computing infrastructure before delivery.

Lithia & Driveway (NYSE:LAD) reported third-quarter 2026 revenue of $9.95 billion, up 2.8% year over year, while net income increased 34% to $292.9 million.

Oil prices climbed more than $1 on Wednesday as escalating Middle East tensions heightened concerns about supply disruptions, while declining U.S. inventories supported crude futures.

Ascentage Pharma (NASDAQ:AAPG) received Breakthrough Therapy Designation in China for lisaftoclax combined with acalabrutinib as a potential first-line treatment for adults with CLL/SLL.

GSK (NYSE:GSK) received U.S. Food and Drug Administration approval for Hibsago (bepirovirsen), an RNA-targeted treatment for certain adults with chronic hepatitis B.

HUTCHMED (NASDAQ:HCM) finalized its licensing agreement with GSK (NYSE:GSK) for investigational cancer therapy HMPL-A830, following completion of customary closing conditions and antitrust regulatory reviews.

Ionis Pharmaceuticals (NASDAQ:IONS) said partner GSK (NYSE:GSK) received U.S. FDA approval for Hibsago, an RNA-targeted treatment for certain adults with chronic hepatitis B.

Woodside Energy Group (NYSE:WDS) reported third-quarter 2026 operating revenue of $4.28 billion, up 2% sequentially, supported by stronger LNG prices and higher production.

Hudbay Minerals (NYSE:HBM) and Mitsubishi Corporation approved construction of the Copper World copper mine in Arizona, with first production targeted for the second half of 2029.

Netflix (NASDAQ:NFLX) reported third-quarter 2026 revenue of $12.87 billion, up 11.8% year over year, supported by subscription pricing, membership growth and advertising.

SpaceX (NASDAQ:SPCX) generated third-quarter 2026 revenue of $14.58 billion, exceeding analysts' $12.7 billion forecast as its AI and connectivity businesses expanded.

United Airlines (NASDAQ:UAL) reported record third-quarter 2026 operating revenue of $17.9 billion, up 17.4% year over year, supported by passenger and loyalty demand.

Phillips 66 (NYSE:PSX) locked out union-represented employees at its Bayway Refinery in Linden, New Jersey, after a temporary labor contract extension expired.

Creative Medical Technology Holdings (NASDAQ:CELZ) reported that 28 of 30 patients, or 93%, met study-defined response criteria in its Ultrasome knee osteoarthritis pilot.

GE Aerospace (NYSE:GE) reported third-quarter 2026 GAAP revenue of $14.12 billion, up 16% year over year, as demand for aircraft engines and maintenance remained strong.

Southern First Bancshares (NASDAQ:SFST) reported third-quarter 2026 net income of $12.2 million, up 41.2% year over year, supported by stronger lending income.

Rapport Therapeutics (NASDAQ:RAPP) reported that its Phase 2 trial of RAP-219 in adults with acute bipolar mania met both primary and secondary endpoints.

KeyCorp (NYSE:KEY) reported third-quarter 2026 net income from continuing operations attributable to common shareholders of $537 million, up 18.3% year over year.